Cerebrovascular involvement in liposome-induced cardiopulmonary distress in pigs

Journal of Liposome Research

Volumn 15, Issue 1-2, 2005, Pages 3-14

  Bodo, Michael ^a   Szebeni, Janos ^a   Baranyi, Lajos ^a   Savay, Sandor ^a   Pearce, Frederick J ^a   Alving, Carl R ^a   Bünger, Rolf ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Cerebrovascular reactivity; Complement activation; Liposome; Rheoencephalogram

Indexed keywords

DOXORUBICIN; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; BRAIN BLOOD FLOW; CARDIOPULMONARY INSUFFICIENCY; CEREBROVASCULAR DISEASE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG INFUSION; HEART ARRHYTHMIA; HEART OUTPUT; HEMODYNAMICS; HYPOTENSION; IMPEDANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RHEOENCEPHALOGRAPHY; SWINE; TACHYCARDIA;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARDIOVASCULAR DISEASES; CEREBROVASCULAR CIRCULATION; DOXORUBICIN; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAPHY; HEMODYNAMIC PROCESSES; HUMANS; LIPOSOMES; MALE; REGIONAL BLOOD FLOW; RHEOLOGY; SWINE;

EID: 22144463132     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.1081/LPR-64523     Document Type: Article

References (53)

1. Anonymous (1997). Rheoencephalograph. (a) Identification. In: Code of Federal Regulations. Washington, D.C.: U.S. Government Printing Office, Vol. 8. Title 21, Parts 800 to 1299. Revised as of April 1, 1997.
2. Anonymous (2002). Doxorubicin. www.MayoClinic.com Drug Information>USP Drug Guide-Drug Information.htm, 3/3/2002.
3. (1980). Moskalenko, Y. E., ed. Biophysical Aspects of Cerebral Circulation. Oxford: Pergamon.
4. Bodo, M., Racz, J., Ilias, L., Pasztor, A., Vajda, J., Weinstein, G. B., Pasztor, E., Moskalenko, Y. E. (1986). Rheoencephalographic changes during increased intracranial pressure. In: Krieglstein, J., ed. Pharmacology of Cerebral Ischemia. Amsterdam: Elsevier, pp. 265-269.
5. Bodo, M., Pearce, F. J., Thuroczy, G., Braisted, J., Montgomery, L. D., Kubinyi, G., Forcino, D., Baranyi, L., Heilig, J., Nagy, I., Morrissette, C., Lee, J. (2001). Electrical impedance validations: in vitro and in vivo studies. In: Grimmes, S., Martinsen, O. G., Bruvoll, H., eds. Biophysical Aspects of Cerebral Circulation. Oslo: Unipob Vorlag, June 17-21, pp. 325-329.
6. Bodo, M., Pearce, F. J., Montgomery, L. D., Rosenthal, M., Kubinyi, G., Thuroczy, G., Braisted, J., Forcino, D., Morrissette, C., Nagy, I. (2003). Measurement of brain electrical impedance: animal studies in rheoencephalography. Aviat. Space Environ. Med. 74:506-511.
7. Bodo, M., Pearce, F. J., Armonda, R. A. (2004). Cerebral blood flow changes: rat studies in rheoencephalography. Physiol Meas 25:1371-1384.
8. Bodo, M., Pearce, F. J., Baranyi, L., Armonda, R. A. (2005). Changes in the intracranial rheoencephalogram at lower limit of cerebral blood flow autoregulation. Physiol. Meas. 26:S1-S17.
9. Chillon, J. M., Baumbach, G. L. (2002). Autoregulation: arterial and intracranial pressure. In: Edvinsson, L., Krause, D. N., eds. Cerebral Blood Flow and Metabolism. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, pp. 395-412.
10. Dirnagl, U., Lindauer, U., Them, A., Schreiber, S., Pfister, H. W., Koedel, U., Reszka, R., Freyer, D., Villringer, A. (1995). Global cerebral ischemia in the rat: online monitoring of oxygen free radical production using chemiluminescence in vivo. J Cereb Blood Flow Metab 15:929-940.
11. Ekstrom-Jodal, B., Haggendal, E., Larsson, L. E. (1982). Cerebral blood flow and oxygen uptake in endotoxic shock: an experimental study in dogs. Acta Anaesthesiol. Scand. 26:163-170.
12. Ganong, W. F. (2001). Review of Medical Physiology. 20th ed. New York: Lange.
13. Gabizon, A., Muggia, F. M. (1998). Initial clinical evaluation of pegylated liposomal doxorubicin in solid tumors. In: Woodle, M. C., ed. Long-Circulating Liposomes: Old Drugs, New Therapeutics. Austin: Landes Bioscience, pp. 155-174.
14. Geddes, L. A., Baker, L. E. (1989). Principles of Applied Biomedical Instrumentation. 3rd ed. New York: Wiley.
15. Hadjiev, D. (1968). A new method for quantitative evaluation of cerebral blood flow by rheoencephalography. Brain Res 8:213-215.
16. In: Markovich, S. E., ed. International Conference on Bioelectrical Impedance. Vol. 170. Annals of New York Academy of Sciences, pp. 407-836. Art. 2.
17. Jacquy, J., Dekoninck, W. J., Piraux, A., Calay, R., Bacq, J., Levy, D., Noel, G. (1974). Cerebral blood flow and quantitative rheoencephalography. Electroencephalogr. Clin. Neurophysiol. 37:507-511.
18. Jenkner, F. L. (1986). Clinical Rheonecephalography: A Non-Invasive Method for Automatic Evaluation of Cerebral Hemodynamics. Vienna: Ertldruck.
19. Johansson, B. B. (1992). Experimental models of altering the blood-brain barrier. Prog. Brain. Res. 91:171-175.
20. Kalyanaraman, B., Joseph, J., Kalivendi, S., Wang, S., Konorev, E., Kotamraju, S. (2002). Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol. Cell. Biochem. 234-235:119-124.
21. Kapin, M. A., Law, W. R., Raymond, R. M., Ferguson, J. L. (1986). The cerebral circulatory response during canine anaphylactic shock. Circ. Shock 120:115-125.
22. Kontos, H. A., Wei, E. P., Navari, R. M., Levasseur, J. E., Rosenblum, W. I., Patterson, J. L. Jr. (1978). Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am. J. Physiol. Heart Circ. Physiol. 34:H371-H383.
23. Krause, R. S. (1999). Anaphylaxis. http://emedicine.com/emerg/topics25. htm 12/24/99.
24. Krause, D. N. (2002). Endothelial regulation. In: Edvinsson, L., Krause, D. N., eds. Cerebral Blood Flow and Metabolism. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, pp. 107-118.
25. Lang, E. W., Chesnut, R. M. (2000). A bedside method for investigating the integrity and critical thresholds of cerebral perfusion pressure autoregulation in severe traumatic brain injury patients. Br. J. Neurosurg. 14:117-126.
26. Laverman, P., Boerman, O. C., Oyen, W. J. G., Corstens, F. H. M., Storm, G. (2001). In vivo applications of PEG-liposomes: unexpected observations. Crit. Rev. Ther. Drug. Carr. Syst. 18:551-566.
27. Mamot, C., Drummond, D. C., Greiser, U., Hong, K., Kirpotin, D. B., Marks, J. D., Park, J. W. (2003). Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR-and EGFRvIII-overexpressing tumor cells. Cancer Res. 15(63-12):3154-3161.
28. Marceau, F., Lundberg, C., Hugli, T. E. (1987). Effects of anaphylatoxins on circulation. Immunopharmacol 14:67-84.
29. McLean, J. W., Fox, E. A., Baluk, P., Bolton, P. B., Haskell, A., Pearlman, R., Thurston, G., Umemoto, E. Y., McDonald, D. M. (1997). Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am. J. Physiol. 273:H387-H404.
30. Miller, C. F., Breslow, M. J., Shapiro, R. M., Traystman, R. J. (1987). Role of hypotension in decreasing cerebral blood flow in porcine endotoxemia. Am. J. Physiol. 253(4 Pt 2):H956-H964.
31. Moibenko, A. A., Grabovskii, L. A., Kotsiuruba, V. N., Bulakh, V. N., Tumanovskaia, L. V., Azarov, V. I., Butovich, I. A. (1994). The mechanisms of the changes in coronary vascular resistance in anaphylactic shock. Fiziol. Z. Im. I. M. Sechenova 80:77-82.
32. Pacher, P., Liaudet, L., Bai, P., Mabley, J. G., Kaminski, P. M., Virag, L., Deb, A., Szabo, E., Ungvari, Z., Wolin, M. S., Groves, J. T., Szabo, C. (2003). Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107:896-904.
33. Panerai, R. B. (1998). Assessment of cerebral pressure autoregulation in humans-a review of measurement methods. Physiol. Meas. 19:305-338.
34. Parker, J. L., Emerson, T. E. Jr. (1977). Cerebral hemodynamics, vascular reactivity, and metabolism during canine endotoxin shock. Circ. Shock 4:4153.
35. Patterson, R. (1995). Bioelectric impedance measurement. In: Bronzino, J. D., ed. The Biomedical Engineering Handbook. Boca Raton: CRC Press, pp. 1223-1230.
36. Popesko, P. (1979). Atlas of Topographical Anatomy of the Domestic Animals. Vol. 1. 3rd ed. Philadelphia: Saunders (Bratislava: Priroda).
37. Saito, A., Narasimhan, P., Hayashi, T., Okuno, S., Ferrand-Drake, M., Chan, P. H. (2004). Neuroprotective role of a proline-rich akt substrate in apoptotic neuronal cell death after stroke: relationships with nerve growth factor. J. Neurosci. 24:1584-1593; doi:10.1523/JNEUROSCI.5209-03.
38. Shi, N., Pardridge, W. M. (2000). Non-invasive gene targeting to the brain. Proc. Natl. Acad. Sci. U. S. A. 97:7567-7572.
39. Speth, P. A., van Hoesel, Q. G., Haanen, C. (1988). Clinical pharmacokinetics of doxorubicin. Clin. Pharmacokinet. 15:15-31.
40. Strandgaard, S., Paulson, O. B. (1984). Cerebral autoregulation. Stroke 15:413-416.
41. Szebeni, J., Fontana, J. L., Wassef, N. M., Mongan, P. D., Morse, D. S., Dobbins, D. E., Stahl, G. L., Bunger, R., Alving, C. R. (1999). Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudo-allergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody. Circulation 99:2302-2309.
42. Szebeni, J., Baranyi, L., Savay, S., Lutz, H. U., Jelezarova, E., Bunger, R., Alving, C. R. (2000). The role of complement activation in hypersensitivity to pegylated liposomal doxorubicin (Doxil®). J. Liposome. Res. 10:467-481.
43. Szebeni, J., Baranyi, L., Savay, S., Bodo, M., Morse, D.S., Basta, M., Bunger, R., Alving, C.R. (2000). Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction. Am. J. Physiol. Heart Circ. Physiol. 279:H1319-H1328.
44. Szebeni, J., Baranyi, L., Savay, S., Milosevits, J., Bunger, R., Laverman, P., Metselaar, J. M., Storm, G., Chanan-Khan, A., Liebes, L., Muggia, F. M., Cohen, R., Barenholz, Y., Alving, C. R. (2002). The role of complement activation in hypersensitivity reactions to Doxil and hynic PEG liposomes: experimental and clinical studies. J. Liposome Res. 12:165-172.
45. Takada, G., Onodera, H., Tada, K. (1982). Delivery of fungal beta-galactosidase to rat brain by means of liposomes. Tohoku J. Exp. Med. 136:219-229.
46. Toyoda, K., Chu, Y., Heistad, D. D. (2003). Gene therapy for cerebral vascular disease: update. Br J Pharmacol. 139:1-9; doi: 10.1038/sj.bjp.0705217.
47. Uziely, B., Jeffers, S., Isacson, R., Kutsch, K., Wei-Tsao, D., Yehoshua, Z., Libson, E., Muggia, F. M., Gabizon, A. (1995). Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. J. Clin. Oncol. 13:1777-1785.
48. Vainrub, A., Li, T. B., Fofanov, Y., Pettott, B. M. (2004). Theoretical considerations for the efficient design DNA arrays. In: Moore, J., Zouridakis, G., eds. Biomedical Technology and Devices Handbook. Boca Raton, FL: CRC Press, 14-1-14.
49. Vasquez-Vivar, J., Martasek, P., Hogg, N., Masters, B. S., Pritchard, K. A. Jr., Kalyanaraman, B. (1997). Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry 36(38): 11293-11297.
50. Wang, S. C., Zhang, L., Hortobagyi, G. N., Hung, M. C. (2001). Targeting HER2: recent developments and future directions for breast cancer patients. Semin. Oncol. 28(6 suppl 18):21-29.
51. Westerlind, A., Larsson, L. E., Haggendal, J., Ekstrom-Jodal, B. (1991). Prevention of endotoxin-induced increase of cerebral oxygen consumption in dogs by propranolol pretreatment. Acta Anaesthesiol. Scand. 35:745-749.
52. Yee, S., Safra, T., Jeffers, S., Rosales, R., Teitelbaum, A. (1998). Prevention and Management of Doxil-Related Side Effects: Basic Strategies. ID Number: 281 http://www.asco.org/prof/me/html/98abstracts/asc/m_281.htm3/4/2002.
53. Yoshimura, S., Morishita, R., Hayashi, K., Kokuzawa, J., Aoki, M., Matsumoto, K., Nakamura, T., Ogihara, T., Sakai, N., Kaneda, Y. (2002). Gene transfer of hepatocyte growth factor to subarachnoid space in cerebral hypoperfusion model. Hypertension 39:1028-1034.